Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 48,150
+400 (0.84%)
Sep 17, 2026, 3:30 PM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.45 trillion as of September 17, 2026. Its market cap has increased by 48.91% in one year.
Market Cap
2.45T
Enterprise Value
2.46T
Revenue
162.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
48,150.00
ChartMarket Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.45T, an increase of 9,211.35%. That is a compound annual growth rate of 15.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.45T | 10.23% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.37T |
| Yuhan | 5.77T |
| Celltrion Pharm | 1.72T |
| GC Biopharma | 1.40T |
| Daewoong Pharmaceutical | 1.25T |
| Chong Kun Dang Pharmaceutical | 864.35B |
| Boryung | 737.79B |
| Daewoong | 664.60B |